APA (7th ed.) Citation

Feng Du, Fangchao Zheng, Ying Han, Jiuda Zhao, & Peng Yuan. (2022). Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in ER (+) and/or PR (+) and HER2 (−) Breast Cancer. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Feng Du, Fangchao Zheng, Ying Han, Jiuda Zhao, and Peng Yuan. Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in ER (+) And/or PR (+) and HER2 (−) Breast Cancer. Frontiers Media S.A., 2022.

MLA (9th ed.) Citation

Feng Du, et al. Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in ER (+) And/or PR (+) and HER2 (−) Breast Cancer. Frontiers Media S.A., 2022.